{"id":"https://openalex.org/W2010852471","doi":"https://doi.org/10.1002/cne.20540","title":"Withdrawal from progesterone increases expression of \u03b14, \u03b21, and \u03b4 GABAA receptor subunits in neurons in the periaqueductal gray matter in female Wistar rats","display_name":"Withdrawal from progesterone increases expression of \u03b14, \u03b21, and \u03b4 GABAA receptor subunits in neurons in the periaqueductal gray matter in female Wistar rats","alternate_titles":[],"publication_year":2005,"publication_date":"2005-04-15","ids":{"openalex":"https://openalex.org/W2010852471","doi":"https://doi.org/10.1002/cne.20540","mag":"2010852471","pmid":"https://pubmed.ncbi.nlm.nih.gov/15834956"},"language":"en","primary_location":{"id":"doi:10.1002/cne.20540","doi":"https://doi.org/10.1002/cne.20540","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cne.20540","pdf_url":null,"source":{"id":"https://openalex.org/S4210186231","display_name":"The Journal of Comparative Neurology","issn_l":"0021-9967","issn":["0021-9967","0092-7317","1096-9861","1550-7130"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Comparative Neurology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2010852471"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019294944","display_name":"J.L. Griffiths","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jenny Griffiths","raw_affiliation_strings":["Department of Physiology, University of Birmingham, Birmingham B15 2TT, United Kingdom. jlg828@bham.ac.uk","Department of Physiology, University of Birmingham, Birmingham, B15 2TT, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physiology, University of Birmingham, Birmingham B15 2TT, United Kingdom. jlg828@bham.ac.uk","institution_ids":["https://openalex.org/I79619799"]},{"raw_affiliation_string":"Department of Physiology, University of Birmingham, Birmingham, B15 2TT, United Kingdom","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050645796","display_name":"T.A. Lovick","orcid":"https://orcid.org/0000-0002-7329-4607","observed_orcids":["https://orcid.org/0000-0002-7329-4607"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thelma Lovick","raw_affiliation_strings":["Department of Physiology, University of Birmingham, Birmingham, B15 2TT, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physiology, University of Birmingham, Birmingham, B15 2TT, United Kingdom","institution_ids":["https://openalex.org/I79619799"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5019294944"],"corresponding_institution_ids":["https://openalex.org/I79619799"],"apc_list":{"value":5450,"currency":"USD","value_usd":5450},"apc_paid":null,"fwci":1.6446,"has_fulltext":false,"cited_by_count":92,"citation_normalized_percentile":{"value":0.80534804,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"486","issue":"1","first_page":"89","last_page":"97"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9223999977111816,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9223999977111816,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0066999997943639755,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12054","display_name":"Menstrual Health and Disorders","score":0.00559999980032444,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/progesterone-withdrawal","display_name":"progesterone withdrawal","score":0.996999979019165},{"id":"https://openalex.org/keywords/gaba-a-receptor-subunits","display_name":"GABAA receptor subunits","score":0.8700000047683716},{"id":"https://openalex.org/keywords/periaqueductal-gray","display_name":"periaqueductal gray","score":0.9290000200271606},{"id":"https://openalex.org/keywords/panic-disorder","display_name":"panic disorder","score":0.8690000176429749},{"id":"https://openalex.org/keywords/premenstrual-dysphoric-disorder","display_name":"premenstrual dysphoric disorder","score":0.9950000047683716},{"id":"https://openalex.org/keywords/luteal-phase","display_name":"luteal phase","score":0.8040000200271606},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":0.7200000286102295},{"id":"https://openalex.org/keywords/gabaergic-inhibition","display_name":"GABAergic inhibition","score":0.8299999833106995},{"id":"https://openalex.org/keywords/female-rats","display_name":"female rats","score":0.6380000114440918}],"concepts":[{"id":"https://openalex.org/C2778015638","wikidata":"https://www.wikidata.org/wiki/Q2728811","display_name":"Premenstrual dysphoric disorder","level":4,"score":0.837769091129303},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7607086300849915},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7502554655075073},{"id":"https://openalex.org/C2781069035","wikidata":"https://www.wikidata.org/wiki/Q1243765","display_name":"Periaqueductal gray","level":4,"score":0.6413254141807556},{"id":"https://openalex.org/C2778338918","wikidata":"https://www.wikidata.org/wiki/Q2482223","display_name":"Allopregnanolone","level":5,"score":0.6404577493667603},{"id":"https://openalex.org/C2779177108","wikidata":"https://www.wikidata.org/wiki/Q18356742","display_name":"GABAergic","level":3,"score":0.5686661005020142},{"id":"https://openalex.org/C143228043","wikidata":"https://www.wikidata.org/wiki/Q2363481","display_name":"Luteal phase","level":3,"score":0.5351238250732422},{"id":"https://openalex.org/C168258287","wikidata":"https://www.wikidata.org/wiki/Q60147","display_name":"GABAA receptor","level":3,"score":0.5337594151496887},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5003616809844971},{"id":"https://openalex.org/C2777529043","wikidata":"https://www.wikidata.org/wiki/Q741713","display_name":"Panic disorder","level":3,"score":0.493340402841568},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4859529733657837},{"id":"https://openalex.org/C98717036","wikidata":"https://www.wikidata.org/wiki/Q14872994","display_name":"Progesterone receptor","level":5,"score":0.4748844504356384},{"id":"https://openalex.org/C44796713","wikidata":"https://www.wikidata.org/wiki/Q2659374","display_name":"Neuroactive steroid","level":4,"score":0.47125840187072754},{"id":"https://openalex.org/C2776801781","wikidata":"https://www.wikidata.org/wiki/Q18344323","display_name":"Pregnanolone","level":5,"score":0.4456143379211426},{"id":"https://openalex.org/C2780712732","wikidata":"https://www.wikidata.org/wiki/Q208450","display_name":"Panic","level":3,"score":0.42633044719696045},{"id":"https://openalex.org/C2779058012","wikidata":"https://www.wikidata.org/wiki/Q83864","display_name":"Menstrual cycle","level":3,"score":0.40363550186157227},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.3553162217140198},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.22734683752059937},{"id":"https://openalex.org/C552161191","wikidata":"https://www.wikidata.org/wiki/Q185080","display_name":"Midbrain","level":3,"score":0.2227209508419037},{"id":"https://openalex.org/C187785154","wikidata":"https://www.wikidata.org/wiki/Q5464664","display_name":"Follicular phase","level":2,"score":0.19028544425964355},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.1811647117137909},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.16274872422218323},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.1426422894001007},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.1426229178905487},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0894114077091217},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.0},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010487","descriptor_name":"Periaqueductal Gray","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D010487","descriptor_name":"Periaqueductal Gray","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011293","descriptor_name":"Premenstrual Syndrome","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011374","descriptor_name":"Progesterone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016584","descriptor_name":"Panic Disorder","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D021122","descriptor_name":"Protein Subunits","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D030762","descriptor_name":"Estrous Cycle","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/cne.20540","doi":"https://doi.org/10.1002/cne.20540","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cne.20540","pdf_url":null,"source":{"id":"https://openalex.org/S4210186231","display_name":"The Journal of Comparative Neurology","issn_l":"0021-9967","issn":["0021-9967","0092-7317","1096-9861","1550-7130"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Comparative Neurology","raw_type":"journal-article"},{"id":"pmid:15834956","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15834956","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of comparative neurology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/08e328dd-4d4f-42d9-81be-ba2014e8d6f5","doi":null,"is_oa":false,"landing_page_url":"https://research.birmingham.ac.uk/en/publications/08e328dd-4d4f-42d9-81be-ba2014e8d6f5","pdf_url":null,"source":{"id":"https://openalex.org/S4306402634","display_name":"University of Birmingham Research Portal (University of Birmingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79619799","host_organization_name":"University of Birmingham","host_organization_lineage":["https://openalex.org/I79619799"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Griffiths, J & Lovick, T 2005, 'Withdrawal from progesterone increases expression of alpha 4, beta 1 and delta GABA A receptor subunits in neurons in the periaqueductal gray matter in female Wistar rats', The Journal of Comparative Neurology, vol. 486, pp. 89-97. https://doi.org/10.1002/cne.20540","raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W1032835256","https://openalex.org/W1647312149","https://openalex.org/W1771372085","https://openalex.org/W1839802520","https://openalex.org/W1911099943","https://openalex.org/W1921693572","https://openalex.org/W1966126679","https://openalex.org/W1966745635","https://openalex.org/W1967318820","https://openalex.org/W1970978793","https://openalex.org/W1971122413","https://openalex.org/W1973552869","https://openalex.org/W1977787204","https://openalex.org/W1984967391","https://openalex.org/W1990291379","https://openalex.org/W1996185004","https://openalex.org/W2001744091","https://openalex.org/W2004315771","https://openalex.org/W2004546008","https://openalex.org/W2006550065","https://openalex.org/W2009410204","https://openalex.org/W2012067598","https://openalex.org/W2024394464","https://openalex.org/W2024598414","https://openalex.org/W2025256394","https://openalex.org/W2029466154","https://openalex.org/W2036583721","https://openalex.org/W2036690788","https://openalex.org/W2038415949","https://openalex.org/W2062186332","https://openalex.org/W2074924866","https://openalex.org/W2081626609","https://openalex.org/W2082128892","https://openalex.org/W2083552615","https://openalex.org/W2085633489","https://openalex.org/W2090933475","https://openalex.org/W2093837465","https://openalex.org/W2112256560","https://openalex.org/W2113281603","https://openalex.org/W2117322953","https://openalex.org/W2143098549","https://openalex.org/W2158649743","https://openalex.org/W2187021701","https://openalex.org/W2192386124","https://openalex.org/W2330101560","https://openalex.org/W2336638948","https://openalex.org/W2416624752"],"related_works":["https://openalex.org/W1509009650","https://openalex.org/W1990291379","https://openalex.org/W2024394464","https://openalex.org/W2014760247","https://openalex.org/W2074924866","https://openalex.org/W2008913602","https://openalex.org/W4321613412","https://openalex.org/W1647312149","https://openalex.org/W4412585478"],"abstract_inverted_index":{"Premenstrual":[0],"dysphoric":[1],"disorder":[2,13],"(PMDD)":[3],"shows":[4],"comorbidity":[5],"with":[6,184],"other":[7],"psychiatric":[8],"conditions":[9,19],"such":[10],"as":[11],"panic":[12,61,231],"(PD).":[14],"The":[15,36,155,167],"symptoms":[16],"of":[17,27,42,49,63,142,149,164,186,189,238],"both":[18],"are":[20],"exacerbated":[21],"during":[22,233],"the":[23,28,40,60,64,89,140,147,161,165,171,190,203,215,225,234,239],"late":[24,235],"luteal":[25,236],"phase":[26,237],"menstrual":[29,240],"cycle,":[30],"when":[31],"progesterone":[32,45,103,121,179,221],"levels":[33,180],"fall":[34],"sharply.":[35],"present":[37,85,145],"study":[38],"investigated":[39],"effect":[41,156],"withdrawal":[43,100,219],"from":[44,101,137,220],"(PWD)":[46],"on":[47,120],"expression":[48,185],"alpha4,":[50,77],"beta1,":[51,78],"and":[52,79,116,129,228,244],"delta":[53,80],"GABA(A)":[54,81,173,210],"receptor":[55,82,174],"subunits":[56,83,175],"in":[57,70,86,91,95,117,146,160,170,199,209,214,242],"neurons":[58,87,144],"within":[59,202],"circuitry":[62],"midbrain":[65],"periaqueductal":[66],"gray":[67],"matter":[68],"(PAG)":[69],"adult":[71],"female":[72],"Wistar":[73],"rats.":[74],"Immunostaining":[75],"for":[76,113,122],"was":[84,152,157],"throughout":[88],"PAG":[90,148,216],"vehicle-treated":[92],"animals":[93,118],"(VEH),":[94],"rats":[96,151],"after":[97],"24":[98],"hours":[99],"a":[102],"dosing":[104],"regime":[105],"(PWD,":[106],"5":[107],"mg":[108],"kg(-1)":[109],"i.p.":[110],"twice":[111],"daily":[112],"6":[114],"days),":[115],"maintained":[119],"7":[123],"days":[124],"(HP).":[125],"Compared":[126],"to":[127,196,218,224,230],"HP":[128],"VEH":[130],"animals,":[131],"which":[132],"did":[133],"not":[134],"differ":[135],"significantly":[136,153],"each":[138],"other,":[139],"number":[141],"immunostained":[143],"PWD":[150],"higher.":[154],"most":[158],"pronounced":[159],"dorsolateral":[162],"column":[163],"PAG.":[166,204],"parallel":[168],"changes":[169,198,208],"three":[172],"suggests":[176],"that":[177,207],"falling":[178],"may":[181,222],"be":[182],"associated":[183],"new":[187],"receptors":[188],"alpha4beta1delta":[191],"subtype.":[192],"This":[193],"could":[194],"lead":[195],"functional":[197],"GABAergic":[200],"transmission":[201],"We":[205],"suggest":[206],"receptor-mediated":[211],"inhibitory":[212],"tone":[213],"consequent":[217],"contribute":[223],"increased":[226],"anxiety":[227],"susceptibility":[229],"seen":[232],"cycle":[241],"PMDD":[243],"PD":[245],"patients.":[246]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2010852471","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
